M. Kobayashi et al., 2 NOVEL MISSENSE MUTATIONS IN CALCIUM-SENSING RECEPTOR GENE ASSOCIATED WITH NEONATAL SEVERE HYPERPARATHYROIDISM, The Journal of clinical endocrinology and metabolism, 82(8), 1997, pp. 2716-2719
Familial hypocalciuric hypercalcemia (FHH) is characterized by lifelon
g asymptomatic hypercalcemia without PTH hypersecretion and is inherit
ed as an autosomal dominant trait with near 100% penetrance. In contra
st, neonatal severe hyperparathyroidism (NSHPT) is a life-threatening
disorder characterized by marked hypercalcemia and PTH hypersecretion.
FHH/NSHPT results from inactivating mutations of the human calcium-se
nsing receptor (Casr) gene on chromosome 3q13.3-24. Nearly 30 differen
t mutations of the Casr gene associated with FHH/NSHPT have been repor
ted previously. In this report, genetic analysis of 1 Japanese NSHPT f
amily revealed 2 novel mutations at codon 185 (CGA-->TGA/Agr-->Ter) in
exon 4 of the Casr gene and at codon 670 (GGG-->GAG/Gly-->Glu) in exo
n 7. The Agr(185)Ter change was shown to occur in the proband's unaffe
cted father and paternal grandmother as well as in the proband. The ot
her mutation in exon 7 was shown in the proband's unaffected mother of
Philippine origin as well as in the proband. This family is the first
case of manifestation of more than 1 mutation in a proband's chromoso
mes; 1 mutation was obtained from the unaffected father, and the other
was from the unaffected mother. Our observations have given us import
ant keys to help elucidate the structure-function relationships of the
Casr.